Abstract
The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 26-31 |
| Number of pages | 6 |
| Journal | Current Opinion in Psychology |
| Volume | 4 |
| DOIs | |
| State | Published - Aug 1 2015 |
Fingerprint
ASJC Scopus subject areas
- Psychology(all)
Cite this
Cognitive therapy to prevent depressive relapse in adults. / Vittengl, Jeffrey R.; Jarrett, Robin B.
In: Current Opinion in Psychology, Vol. 4, 01.08.2015, p. 26-31.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cognitive therapy to prevent depressive relapse in adults
AU - Vittengl, Jeffrey R.
AU - Jarrett, Robin B.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.
AB - The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.
UR - http://www.scopus.com/inward/record.url?scp=84923348267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923348267&partnerID=8YFLogxK
U2 - 10.1016/j.copsyc.2015.01.016
DO - 10.1016/j.copsyc.2015.01.016
M3 - Article
C2 - 25729758
AN - SCOPUS:84923348267
VL - 4
SP - 26
EP - 31
JO - Current Opinion in Psychology
JF - Current Opinion in Psychology
SN - 2352-250X
ER -